đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
Grapefruit juice is an inhibitor of the cytochrome P450 (CYP) 3A4 enzyme sy...
Status
Completed
Location
PRACS Institute, Ltd. - Cetero Research
Start Date
2008-09
Trial ID
NCT00984009
Treatments Being Tested
The CLEAR SYNERGY trial will study the long term effects of treatments foll...
Status
Completed
Location
Central Cardiology
Start Date
2018-02-01
Trial ID
NCT03048825
Ritonavir is a potent inhibitor of CYP3A4, one of the enzymes responsible f...
Status
Completed
Location
PRACS Institute, Ltd. - Cetero Research
Start Date
2008-07
Trial ID
NCT00983515
Treatments Being Tested
Colchicine is a substrate for both cytochrome P450 3A4 (CYP3A4) and P-glyco...
Status
Completed
Location
PRACS Institute, Ltd. - Cetero Research
Start Date
2008-08
Trial ID
NCT00983931
Treatments Being Tested
Azithromycin is a possible weak to moderate inhibitor of CYP3A4, one of the...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00983294
Treatments Being Tested
Colchicine is a substrate for both cytochrome P450 3A4 (CYP3A4) and P-glyco...
Status
Completed
Location
PRACS Institute, Ltd. - Cetero Research
Start Date
2008-08
Trial ID
NCT00983372
Treatments Being Tested
The purpose of this study is to evaluate and compare the relative bioavaila...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01001052
Treatments Being Tested